Global Drug-Eluting Stent Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Drug-Eluting Stent market size is projected to grow from US$ 5824.5 million in 2023 to US$ 7476.2 million in 2030; it is expected to grow at a CAGR of 3.6% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Drug-Eluting Stent Industry Forecast” looks at past sales and reviews total world Drug-Eluting Stent sales in 2023, providing a comprehensive analysis by region and market sector of projected Drug-Eluting Stent sales for 2024 through 2030. With Drug-Eluting Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Eluting Stent industry.
This Insight Report provides a comprehensive analysis of the global Drug-Eluting Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-Eluting Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug-Eluting Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Eluting Stent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Eluting Stent.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Eluting Stent market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global Drug-Eluting Stent market?
What factors are driving Drug-Eluting Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug-Eluting Stent market opportunities vary by end market size?
How does Drug-Eluting Stent break out type, application?
The global Drug-Eluting Stent market size is projected to grow from US$ 5824.5 million in 2023 to US$ 7476.2 million in 2030; it is expected to grow at a CAGR of 3.6% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Drug-Eluting Stent Industry Forecast” looks at past sales and reviews total world Drug-Eluting Stent sales in 2023, providing a comprehensive analysis by region and market sector of projected Drug-Eluting Stent sales for 2024 through 2030. With Drug-Eluting Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Eluting Stent industry.
This Insight Report provides a comprehensive analysis of the global Drug-Eluting Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-Eluting Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug-Eluting Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Eluting Stent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Eluting Stent.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Eluting Stent market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- Rapamycin Eluting Stent
- Paclitaxel Eluting Stent
- Everolimus Eluting Stent
- Others
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boston Scientific
- Medtronic
- Abbott
- Lepu Medical
- B. Braun Melsungen
- MicroPort Scientific
- Cook Medical
- Terumo
- Biosensors International
- Balton
- AlviMedica Medical Technologies
- Biotronik
- Shandong JW Medical
- Sino Medical
- Beijing AMSINO
What is the 10-year outlook for the global Drug-Eluting Stent market?
What factors are driving Drug-Eluting Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug-Eluting Stent market opportunities vary by end market size?
How does Drug-Eluting Stent break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-Eluting Stent Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Drug-Eluting Stent by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Drug-Eluting Stent by Country/Region, 2019, 2023 & 2030
2.2 Drug-Eluting Stent Segment by Type
2.2.1 Rapamycin Eluting Stent
2.2.2 Paclitaxel Eluting Stent
2.2.3 Everolimus Eluting Stent
2.2.4 Others
2.3 Drug-Eluting Stent Sales by Type
2.3.1 Global Drug-Eluting Stent Sales Market Share by Type (2019-2024)
2.3.2 Global Drug-Eluting Stent Revenue and Market Share by Type (2019-2024)
2.3.3 Global Drug-Eluting Stent Sale Price by Type (2019-2024)
2.4 Drug-Eluting Stent Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Drug-Eluting Stent Sales by Application
2.5.1 Global Drug-Eluting Stent Sale Market Share by Application (2019-2024)
2.5.2 Global Drug-Eluting Stent Revenue and Market Share by Application (2019-2024)
2.5.3 Global Drug-Eluting Stent Sale Price by Application (2019-2024)
3 GLOBAL DRUG-ELUTING STENT BY COMPANY
3.1 Global Drug-Eluting Stent Breakdown Data by Company
3.1.1 Global Drug-Eluting Stent Annual Sales by Company (2019-2024)
3.1.2 Global Drug-Eluting Stent Sales Market Share by Company (2019-2024)
3.2 Global Drug-Eluting Stent Annual Revenue by Company (2019-2024)
3.2.1 Global Drug-Eluting Stent Revenue by Company (2019-2024)
3.2.2 Global Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
3.3 Global Drug-Eluting Stent Sale Price by Company
3.4 Key Manufacturers Drug-Eluting Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Eluting Stent Product Location Distribution
3.4.2 Players Drug-Eluting Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG-ELUTING STENT BY GEOGRAPHIC REGION
4.1 World Historic Drug-Eluting Stent Market Size by Geographic Region (2019-2024)
4.1.1 Global Drug-Eluting Stent Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Drug-Eluting Stent Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Drug-Eluting Stent Market Size by Country/Region (2019-2024)
4.2.1 Global Drug-Eluting Stent Annual Sales by Country/Region (2019-2024)
4.2.2 Global Drug-Eluting Stent Annual Revenue by Country/Region (2019-2024)
4.3 Americas Drug-Eluting Stent Sales Growth
4.4 APAC Drug-Eluting Stent Sales Growth
4.5 Europe Drug-Eluting Stent Sales Growth
4.6 Middle East & Africa Drug-Eluting Stent Sales Growth
5 AMERICAS
5.1 Americas Drug-Eluting Stent Sales by Country
5.1.1 Americas Drug-Eluting Stent Sales by Country (2019-2024)
5.1.2 Americas Drug-Eluting Stent Revenue by Country (2019-2024)
5.2 Americas Drug-Eluting Stent Sales by Type
5.3 Americas Drug-Eluting Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Eluting Stent Sales by Region
6.1.1 APAC Drug-Eluting Stent Sales by Region (2019-2024)
6.1.2 APAC Drug-Eluting Stent Revenue by Region (2019-2024)
6.2 APAC Drug-Eluting Stent Sales by Type
6.3 APAC Drug-Eluting Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-Eluting Stent by Country
7.1.1 Europe Drug-Eluting Stent Sales by Country (2019-2024)
7.1.2 Europe Drug-Eluting Stent Revenue by Country (2019-2024)
7.2 Europe Drug-Eluting Stent Sales by Type
7.3 Europe Drug-Eluting Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-Eluting Stent by Country
8.1.1 Middle East & Africa Drug-Eluting Stent Sales by Country (2019-2024)
8.1.2 Middle East & Africa Drug-Eluting Stent Revenue by Country (2019-2024)
8.2 Middle East & Africa Drug-Eluting Stent Sales by Type
8.3 Middle East & Africa Drug-Eluting Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Eluting Stent
10.3 Manufacturing Process Analysis of Drug-Eluting Stent
10.4 Industry Chain Structure of Drug-Eluting Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Eluting Stent Distributors
11.3 Drug-Eluting Stent Customer
12 WORLD FORECAST REVIEW FOR DRUG-ELUTING STENT BY GEOGRAPHIC REGION
12.1 Global Drug-Eluting Stent Market Size Forecast by Region
12.1.1 Global Drug-Eluting Stent Forecast by Region (2025-2030)
12.1.2 Global Drug-Eluting Stent Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-Eluting Stent Forecast by Type
12.7 Global Drug-Eluting Stent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Drug-Eluting Stent Product Portfolios and Specifications
13.1.3 Boston Scientific Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug-Eluting Stent Product Portfolios and Specifications
13.2.3 Medtronic Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Drug-Eluting Stent Product Portfolios and Specifications
13.3.3 Abbott Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Lepu Medical
13.4.1 Lepu Medical Company Information
13.4.2 Lepu Medical Drug-Eluting Stent Product Portfolios and Specifications
13.4.3 Lepu Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lepu Medical Main Business Overview
13.4.5 Lepu Medical Latest Developments
13.5 B. Braun Melsungen
13.5.1 B. Braun Melsungen Company Information
13.5.2 B. Braun Melsungen Drug-Eluting Stent Product Portfolios and Specifications
13.5.3 B. Braun Melsungen Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 B. Braun Melsungen Main Business Overview
13.5.5 B. Braun Melsungen Latest Developments
13.6 MicroPort Scientific
13.6.1 MicroPort Scientific Company Information
13.6.2 MicroPort Scientific Drug-Eluting Stent Product Portfolios and Specifications
13.6.3 MicroPort Scientific Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 MicroPort Scientific Main Business Overview
13.6.5 MicroPort Scientific Latest Developments
13.7 Cook Medical
13.7.1 Cook Medical Company Information
13.7.2 Cook Medical Drug-Eluting Stent Product Portfolios and Specifications
13.7.3 Cook Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Cook Medical Main Business Overview
13.7.5 Cook Medical Latest Developments
13.8 Terumo
13.8.1 Terumo Company Information
13.8.2 Terumo Drug-Eluting Stent Product Portfolios and Specifications
13.8.3 Terumo Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Terumo Main Business Overview
13.8.5 Terumo Latest Developments
13.9 Biosensors International
13.9.1 Biosensors International Company Information
13.9.2 Biosensors International Drug-Eluting Stent Product Portfolios and Specifications
13.9.3 Biosensors International Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Biosensors International Main Business Overview
13.9.5 Biosensors International Latest Developments
13.10 Balton
13.10.1 Balton Company Information
13.10.2 Balton Drug-Eluting Stent Product Portfolios and Specifications
13.10.3 Balton Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Balton Main Business Overview
13.10.5 Balton Latest Developments
13.11 AlviMedica Medical Technologies
13.11.1 AlviMedica Medical Technologies Company Information
13.11.2 AlviMedica Medical Technologies Drug-Eluting Stent Product Portfolios and Specifications
13.11.3 AlviMedica Medical Technologies Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 AlviMedica Medical Technologies Main Business Overview
13.11.5 AlviMedica Medical Technologies Latest Developments
13.12 Biotronik
13.12.1 Biotronik Company Information
13.12.2 Biotronik Drug-Eluting Stent Product Portfolios and Specifications
13.12.3 Biotronik Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Biotronik Main Business Overview
13.12.5 Biotronik Latest Developments
13.13 Shandong JW Medical
13.13.1 Shandong JW Medical Company Information
13.13.2 Shandong JW Medical Drug-Eluting Stent Product Portfolios and Specifications
13.13.3 Shandong JW Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Shandong JW Medical Main Business Overview
13.13.5 Shandong JW Medical Latest Developments
13.14 Sino Medical
13.14.1 Sino Medical Company Information
13.14.2 Sino Medical Drug-Eluting Stent Product Portfolios and Specifications
13.14.3 Sino Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Sino Medical Main Business Overview
13.14.5 Sino Medical Latest Developments
13.15 Beijing AMSINO
13.15.1 Beijing AMSINO Company Information
13.15.2 Beijing AMSINO Drug-Eluting Stent Product Portfolios and Specifications
13.15.3 Beijing AMSINO Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Beijing AMSINO Main Business Overview
13.15.5 Beijing AMSINO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-Eluting Stent Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Drug-Eluting Stent by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Drug-Eluting Stent by Country/Region, 2019, 2023 & 2030
2.2 Drug-Eluting Stent Segment by Type
2.2.1 Rapamycin Eluting Stent
2.2.2 Paclitaxel Eluting Stent
2.2.3 Everolimus Eluting Stent
2.2.4 Others
2.3 Drug-Eluting Stent Sales by Type
2.3.1 Global Drug-Eluting Stent Sales Market Share by Type (2019-2024)
2.3.2 Global Drug-Eluting Stent Revenue and Market Share by Type (2019-2024)
2.3.3 Global Drug-Eluting Stent Sale Price by Type (2019-2024)
2.4 Drug-Eluting Stent Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Drug-Eluting Stent Sales by Application
2.5.1 Global Drug-Eluting Stent Sale Market Share by Application (2019-2024)
2.5.2 Global Drug-Eluting Stent Revenue and Market Share by Application (2019-2024)
2.5.3 Global Drug-Eluting Stent Sale Price by Application (2019-2024)
3 GLOBAL DRUG-ELUTING STENT BY COMPANY
3.1 Global Drug-Eluting Stent Breakdown Data by Company
3.1.1 Global Drug-Eluting Stent Annual Sales by Company (2019-2024)
3.1.2 Global Drug-Eluting Stent Sales Market Share by Company (2019-2024)
3.2 Global Drug-Eluting Stent Annual Revenue by Company (2019-2024)
3.2.1 Global Drug-Eluting Stent Revenue by Company (2019-2024)
3.2.2 Global Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
3.3 Global Drug-Eluting Stent Sale Price by Company
3.4 Key Manufacturers Drug-Eluting Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Eluting Stent Product Location Distribution
3.4.2 Players Drug-Eluting Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG-ELUTING STENT BY GEOGRAPHIC REGION
4.1 World Historic Drug-Eluting Stent Market Size by Geographic Region (2019-2024)
4.1.1 Global Drug-Eluting Stent Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Drug-Eluting Stent Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Drug-Eluting Stent Market Size by Country/Region (2019-2024)
4.2.1 Global Drug-Eluting Stent Annual Sales by Country/Region (2019-2024)
4.2.2 Global Drug-Eluting Stent Annual Revenue by Country/Region (2019-2024)
4.3 Americas Drug-Eluting Stent Sales Growth
4.4 APAC Drug-Eluting Stent Sales Growth
4.5 Europe Drug-Eluting Stent Sales Growth
4.6 Middle East & Africa Drug-Eluting Stent Sales Growth
5 AMERICAS
5.1 Americas Drug-Eluting Stent Sales by Country
5.1.1 Americas Drug-Eluting Stent Sales by Country (2019-2024)
5.1.2 Americas Drug-Eluting Stent Revenue by Country (2019-2024)
5.2 Americas Drug-Eluting Stent Sales by Type
5.3 Americas Drug-Eluting Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Eluting Stent Sales by Region
6.1.1 APAC Drug-Eluting Stent Sales by Region (2019-2024)
6.1.2 APAC Drug-Eluting Stent Revenue by Region (2019-2024)
6.2 APAC Drug-Eluting Stent Sales by Type
6.3 APAC Drug-Eluting Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-Eluting Stent by Country
7.1.1 Europe Drug-Eluting Stent Sales by Country (2019-2024)
7.1.2 Europe Drug-Eluting Stent Revenue by Country (2019-2024)
7.2 Europe Drug-Eluting Stent Sales by Type
7.3 Europe Drug-Eluting Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-Eluting Stent by Country
8.1.1 Middle East & Africa Drug-Eluting Stent Sales by Country (2019-2024)
8.1.2 Middle East & Africa Drug-Eluting Stent Revenue by Country (2019-2024)
8.2 Middle East & Africa Drug-Eluting Stent Sales by Type
8.3 Middle East & Africa Drug-Eluting Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Eluting Stent
10.3 Manufacturing Process Analysis of Drug-Eluting Stent
10.4 Industry Chain Structure of Drug-Eluting Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Eluting Stent Distributors
11.3 Drug-Eluting Stent Customer
12 WORLD FORECAST REVIEW FOR DRUG-ELUTING STENT BY GEOGRAPHIC REGION
12.1 Global Drug-Eluting Stent Market Size Forecast by Region
12.1.1 Global Drug-Eluting Stent Forecast by Region (2025-2030)
12.1.2 Global Drug-Eluting Stent Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-Eluting Stent Forecast by Type
12.7 Global Drug-Eluting Stent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Drug-Eluting Stent Product Portfolios and Specifications
13.1.3 Boston Scientific Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug-Eluting Stent Product Portfolios and Specifications
13.2.3 Medtronic Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Drug-Eluting Stent Product Portfolios and Specifications
13.3.3 Abbott Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Lepu Medical
13.4.1 Lepu Medical Company Information
13.4.2 Lepu Medical Drug-Eluting Stent Product Portfolios and Specifications
13.4.3 Lepu Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lepu Medical Main Business Overview
13.4.5 Lepu Medical Latest Developments
13.5 B. Braun Melsungen
13.5.1 B. Braun Melsungen Company Information
13.5.2 B. Braun Melsungen Drug-Eluting Stent Product Portfolios and Specifications
13.5.3 B. Braun Melsungen Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 B. Braun Melsungen Main Business Overview
13.5.5 B. Braun Melsungen Latest Developments
13.6 MicroPort Scientific
13.6.1 MicroPort Scientific Company Information
13.6.2 MicroPort Scientific Drug-Eluting Stent Product Portfolios and Specifications
13.6.3 MicroPort Scientific Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 MicroPort Scientific Main Business Overview
13.6.5 MicroPort Scientific Latest Developments
13.7 Cook Medical
13.7.1 Cook Medical Company Information
13.7.2 Cook Medical Drug-Eluting Stent Product Portfolios and Specifications
13.7.3 Cook Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Cook Medical Main Business Overview
13.7.5 Cook Medical Latest Developments
13.8 Terumo
13.8.1 Terumo Company Information
13.8.2 Terumo Drug-Eluting Stent Product Portfolios and Specifications
13.8.3 Terumo Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Terumo Main Business Overview
13.8.5 Terumo Latest Developments
13.9 Biosensors International
13.9.1 Biosensors International Company Information
13.9.2 Biosensors International Drug-Eluting Stent Product Portfolios and Specifications
13.9.3 Biosensors International Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Biosensors International Main Business Overview
13.9.5 Biosensors International Latest Developments
13.10 Balton
13.10.1 Balton Company Information
13.10.2 Balton Drug-Eluting Stent Product Portfolios and Specifications
13.10.3 Balton Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Balton Main Business Overview
13.10.5 Balton Latest Developments
13.11 AlviMedica Medical Technologies
13.11.1 AlviMedica Medical Technologies Company Information
13.11.2 AlviMedica Medical Technologies Drug-Eluting Stent Product Portfolios and Specifications
13.11.3 AlviMedica Medical Technologies Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 AlviMedica Medical Technologies Main Business Overview
13.11.5 AlviMedica Medical Technologies Latest Developments
13.12 Biotronik
13.12.1 Biotronik Company Information
13.12.2 Biotronik Drug-Eluting Stent Product Portfolios and Specifications
13.12.3 Biotronik Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Biotronik Main Business Overview
13.12.5 Biotronik Latest Developments
13.13 Shandong JW Medical
13.13.1 Shandong JW Medical Company Information
13.13.2 Shandong JW Medical Drug-Eluting Stent Product Portfolios and Specifications
13.13.3 Shandong JW Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Shandong JW Medical Main Business Overview
13.13.5 Shandong JW Medical Latest Developments
13.14 Sino Medical
13.14.1 Sino Medical Company Information
13.14.2 Sino Medical Drug-Eluting Stent Product Portfolios and Specifications
13.14.3 Sino Medical Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Sino Medical Main Business Overview
13.14.5 Sino Medical Latest Developments
13.15 Beijing AMSINO
13.15.1 Beijing AMSINO Company Information
13.15.2 Beijing AMSINO Drug-Eluting Stent Product Portfolios and Specifications
13.15.3 Beijing AMSINO Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Beijing AMSINO Main Business Overview
13.15.5 Beijing AMSINO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug-Eluting Stent Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Drug-Eluting Stent Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Rapamycin Eluting Stent
Table 4. Major Players of Paclitaxel Eluting Stent
Table 5. Major Players of Everolimus Eluting Stent
Table 6. Major Players of Others
Table 7. Global Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 8. Global Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Table 9. Global Drug-Eluting Stent Revenue by Type (2019-2024) & ($ million)
Table 10. Global Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Table 11. Global Drug-Eluting Stent Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 13. Global Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Table 14. Global Drug-Eluting Stent Revenue by Application (2019-2024)
Table 15. Global Drug-Eluting Stent Revenue Market Share by Application (2019-2024)
Table 16. Global Drug-Eluting Stent Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Drug-Eluting Stent Sales by Company (2019-2024) & (K Units)
Table 18. Global Drug-Eluting Stent Sales Market Share by Company (2019-2024)
Table 19. Global Drug-Eluting Stent Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
Table 21. Global Drug-Eluting Stent Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Drug-Eluting Stent Producing Area Distribution and Sales Area
Table 23. Players Drug-Eluting Stent Products Offered
Table 24. Drug-Eluting Stent Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Drug-Eluting Stent Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Drug-Eluting Stent Sales Market Share Geographic Region (2019-2024)
Table 29. Global Drug-Eluting Stent Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Drug-Eluting Stent Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Drug-Eluting Stent Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Drug-Eluting Stent Sales Market Share by Country/Region (2019-2024)
Table 33. Global Drug-Eluting Stent Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Drug-Eluting Stent Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 36. Americas Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 37. Americas Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 39. Americas Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 40. Americas Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 41. APAC Drug-Eluting Stent Sales by Region (2019-2024) & (K Units)
Table 42. APAC Drug-Eluting Stent Sales Market Share by Region (2019-2024)
Table 43. APAC Drug-Eluting Stent Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Drug-Eluting Stent Revenue Market Share by Region (2019-2024)
Table 45. APAC Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 46. APAC Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 47. Europe Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 48. Europe Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 49. Europe Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 51. Europe Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 52. Europe Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Drug-Eluting Stent
Table 60. Key Market Challenges & Risks of Drug-Eluting Stent
Table 61. Key Industry Trends of Drug-Eluting Stent
Table 62. Drug-Eluting Stent Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Drug-Eluting Stent Distributors List
Table 65. Drug-Eluting Stent Customer List
Table 66. Global Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Drug-Eluting Stent Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Drug-Eluting Stent Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Drug-Eluting Stent Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Drug-Eluting Stent Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Boston Scientific Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 81. Boston Scientific Drug-Eluting Stent Product Portfolios and Specifications
Table 82. Boston Scientific Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Boston Scientific Main Business
Table 84. Boston Scientific Latest Developments
Table 85. Medtronic Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 86. Medtronic Drug-Eluting Stent Product Portfolios and Specifications
Table 87. Medtronic Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Medtronic Main Business
Table 89. Medtronic Latest Developments
Table 90. Abbott Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 91. Abbott Drug-Eluting Stent Product Portfolios and Specifications
Table 92. Abbott Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Abbott Main Business
Table 94. Abbott Latest Developments
Table 95. Lepu Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 96. Lepu Medical Drug-Eluting Stent Product Portfolios and Specifications
Table 97. Lepu Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Lepu Medical Main Business
Table 99. Lepu Medical Latest Developments
Table 100. B. Braun Melsungen Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 101. B. Braun Melsungen Drug-Eluting Stent Product Portfolios and Specifications
Table 102. B. Braun Melsungen Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. B. Braun Melsungen Main Business
Table 104. B. Braun Melsungen Latest Developments
Table 105. MicroPort Scientific Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 106. MicroPort Scientific Drug-Eluting Stent Product Portfolios and Specifications
Table 107. MicroPort Scientific Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. MicroPort Scientific Main Business
Table 109. MicroPort Scientific Latest Developments
Table 110. Cook Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 111. Cook Medical Drug-Eluting Stent Product Portfolios and Specifications
Table 112. Cook Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Cook Medical Main Business
Table 114. Cook Medical Latest Developments
Table 115. Terumo Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 116. Terumo Drug-Eluting Stent Product Portfolios and Specifications
Table 117. Terumo Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Terumo Main Business
Table 119. Terumo Latest Developments
Table 120. Biosensors International Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 121. Biosensors International Drug-Eluting Stent Product Portfolios and Specifications
Table 122. Biosensors International Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Biosensors International Main Business
Table 124. Biosensors International Latest Developments
Table 125. Balton Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 126. Balton Drug-Eluting Stent Product Portfolios and Specifications
Table 127. Balton Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Balton Main Business
Table 129. Balton Latest Developments
Table 130. AlviMedica Medical Technologies Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 131. AlviMedica Medical Technologies Drug-Eluting Stent Product Portfolios and Specifications
Table 132. AlviMedica Medical Technologies Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. AlviMedica Medical Technologies Main Business
Table 134. AlviMedica Medical Technologies Latest Developments
Table 135. Biotronik Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 136. Biotronik Drug-Eluting Stent Product Portfolios and Specifications
Table 137. Biotronik Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Biotronik Main Business
Table 139. Biotronik Latest Developments
Table 140. Shandong JW Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 141. Shandong JW Medical Drug-Eluting Stent Product Portfolios and Specifications
Table 142. Shandong JW Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Shandong JW Medical Main Business
Table 144. Shandong JW Medical Latest Developments
Table 145. Sino Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 146. Sino Medical Drug-Eluting Stent Product Portfolios and Specifications
Table 147. Sino Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Sino Medical Main Business
Table 149. Sino Medical Latest Developments
Table 150. Beijing AMSINO Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 151. Beijing AMSINO Drug-Eluting Stent Product Portfolios and Specifications
Table 152. Beijing AMSINO Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Beijing AMSINO Main Business
Table 154. Beijing AMSINO Latest Developments
Table 1. Drug-Eluting Stent Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Drug-Eluting Stent Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Rapamycin Eluting Stent
Table 4. Major Players of Paclitaxel Eluting Stent
Table 5. Major Players of Everolimus Eluting Stent
Table 6. Major Players of Others
Table 7. Global Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 8. Global Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Table 9. Global Drug-Eluting Stent Revenue by Type (2019-2024) & ($ million)
Table 10. Global Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Table 11. Global Drug-Eluting Stent Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 13. Global Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Table 14. Global Drug-Eluting Stent Revenue by Application (2019-2024)
Table 15. Global Drug-Eluting Stent Revenue Market Share by Application (2019-2024)
Table 16. Global Drug-Eluting Stent Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Drug-Eluting Stent Sales by Company (2019-2024) & (K Units)
Table 18. Global Drug-Eluting Stent Sales Market Share by Company (2019-2024)
Table 19. Global Drug-Eluting Stent Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
Table 21. Global Drug-Eluting Stent Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Drug-Eluting Stent Producing Area Distribution and Sales Area
Table 23. Players Drug-Eluting Stent Products Offered
Table 24. Drug-Eluting Stent Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Drug-Eluting Stent Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Drug-Eluting Stent Sales Market Share Geographic Region (2019-2024)
Table 29. Global Drug-Eluting Stent Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Drug-Eluting Stent Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Drug-Eluting Stent Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Drug-Eluting Stent Sales Market Share by Country/Region (2019-2024)
Table 33. Global Drug-Eluting Stent Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Drug-Eluting Stent Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 36. Americas Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 37. Americas Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 39. Americas Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 40. Americas Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 41. APAC Drug-Eluting Stent Sales by Region (2019-2024) & (K Units)
Table 42. APAC Drug-Eluting Stent Sales Market Share by Region (2019-2024)
Table 43. APAC Drug-Eluting Stent Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Drug-Eluting Stent Revenue Market Share by Region (2019-2024)
Table 45. APAC Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 46. APAC Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 47. Europe Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 48. Europe Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 49. Europe Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 51. Europe Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 52. Europe Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Drug-Eluting Stent
Table 60. Key Market Challenges & Risks of Drug-Eluting Stent
Table 61. Key Industry Trends of Drug-Eluting Stent
Table 62. Drug-Eluting Stent Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Drug-Eluting Stent Distributors List
Table 65. Drug-Eluting Stent Customer List
Table 66. Global Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Drug-Eluting Stent Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Drug-Eluting Stent Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Drug-Eluting Stent Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Drug-Eluting Stent Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Boston Scientific Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 81. Boston Scientific Drug-Eluting Stent Product Portfolios and Specifications
Table 82. Boston Scientific Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Boston Scientific Main Business
Table 84. Boston Scientific Latest Developments
Table 85. Medtronic Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 86. Medtronic Drug-Eluting Stent Product Portfolios and Specifications
Table 87. Medtronic Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Medtronic Main Business
Table 89. Medtronic Latest Developments
Table 90. Abbott Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 91. Abbott Drug-Eluting Stent Product Portfolios and Specifications
Table 92. Abbott Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Abbott Main Business
Table 94. Abbott Latest Developments
Table 95. Lepu Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 96. Lepu Medical Drug-Eluting Stent Product Portfolios and Specifications
Table 97. Lepu Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Lepu Medical Main Business
Table 99. Lepu Medical Latest Developments
Table 100. B. Braun Melsungen Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 101. B. Braun Melsungen Drug-Eluting Stent Product Portfolios and Specifications
Table 102. B. Braun Melsungen Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. B. Braun Melsungen Main Business
Table 104. B. Braun Melsungen Latest Developments
Table 105. MicroPort Scientific Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 106. MicroPort Scientific Drug-Eluting Stent Product Portfolios and Specifications
Table 107. MicroPort Scientific Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. MicroPort Scientific Main Business
Table 109. MicroPort Scientific Latest Developments
Table 110. Cook Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 111. Cook Medical Drug-Eluting Stent Product Portfolios and Specifications
Table 112. Cook Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Cook Medical Main Business
Table 114. Cook Medical Latest Developments
Table 115. Terumo Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 116. Terumo Drug-Eluting Stent Product Portfolios and Specifications
Table 117. Terumo Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Terumo Main Business
Table 119. Terumo Latest Developments
Table 120. Biosensors International Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 121. Biosensors International Drug-Eluting Stent Product Portfolios and Specifications
Table 122. Biosensors International Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Biosensors International Main Business
Table 124. Biosensors International Latest Developments
Table 125. Balton Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 126. Balton Drug-Eluting Stent Product Portfolios and Specifications
Table 127. Balton Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Balton Main Business
Table 129. Balton Latest Developments
Table 130. AlviMedica Medical Technologies Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 131. AlviMedica Medical Technologies Drug-Eluting Stent Product Portfolios and Specifications
Table 132. AlviMedica Medical Technologies Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. AlviMedica Medical Technologies Main Business
Table 134. AlviMedica Medical Technologies Latest Developments
Table 135. Biotronik Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 136. Biotronik Drug-Eluting Stent Product Portfolios and Specifications
Table 137. Biotronik Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Biotronik Main Business
Table 139. Biotronik Latest Developments
Table 140. Shandong JW Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 141. Shandong JW Medical Drug-Eluting Stent Product Portfolios and Specifications
Table 142. Shandong JW Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Shandong JW Medical Main Business
Table 144. Shandong JW Medical Latest Developments
Table 145. Sino Medical Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 146. Sino Medical Drug-Eluting Stent Product Portfolios and Specifications
Table 147. Sino Medical Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Sino Medical Main Business
Table 149. Sino Medical Latest Developments
Table 150. Beijing AMSINO Basic Information, Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 151. Beijing AMSINO Drug-Eluting Stent Product Portfolios and Specifications
Table 152. Beijing AMSINO Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Beijing AMSINO Main Business
Table 154. Beijing AMSINO Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug-Eluting Stent
Figure 2. Drug-Eluting Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Eluting Stent Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Drug-Eluting Stent Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Drug-Eluting Stent Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Rapamycin Eluting Stent
Figure 10. Product Picture of Paclitaxel Eluting Stent
Figure 11. Product Picture of Everolimus Eluting Stent
Figure 12. Product Picture of Others
Figure 13. Global Drug-Eluting Stent Sales Market Share by Type in 2023
Figure 14. Global Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Figure 15. Drug-Eluting Stent Consumed in Hospitals
Figure 16. Global Drug-Eluting Stent Market: Hospitals (2019-2024) & (K Units)
Figure 17. Drug-Eluting Stent Consumed in Clinics
Figure 18. Global Drug-Eluting Stent Market: Clinics (2019-2024) & (K Units)
Figure 19. Drug-Eluting Stent Consumed in Ambulatory Surgical Centers
Figure 20. Global Drug-Eluting Stent Market: Ambulatory Surgical Centers (2019-2024) & (K Units)
Figure 21. Drug-Eluting Stent Consumed in Others
Figure 22. Global Drug-Eluting Stent Market: Others (2019-2024) & (K Units)
Figure 23. Global Drug-Eluting Stent Sales Market Share by Application (2023)
Figure 24. Global Drug-Eluting Stent Revenue Market Share by Application in 2023
Figure 25. Drug-Eluting Stent Sales Market by Company in 2023 (K Units)
Figure 26. Global Drug-Eluting Stent Sales Market Share by Company in 2023
Figure 27. Drug-Eluting Stent Revenue Market by Company in 2023 ($ Million)
Figure 28. Global Drug-Eluting Stent Revenue Market Share by Company in 2023
Figure 29. Global Drug-Eluting Stent Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Drug-Eluting Stent Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 32. Americas Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 33. APAC Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 34. APAC Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 35. Europe Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 36. Europe Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 37. Middle East & Africa Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 39. Americas Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 40. Americas Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 41. Americas Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 42. Americas Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 43. United States Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 44. Canada Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 45. Mexico Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 46. Brazil Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 47. APAC Drug-Eluting Stent Sales Market Share by Region in 2023
Figure 48. APAC Drug-Eluting Stent Revenue Market Share by Regions in 2023
Figure 49. APAC Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 50. APAC Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 51. China Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 52. Japan Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 53. South Korea Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 54. Southeast Asia Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 55. India Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 56. Australia Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 57. China Taiwan Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 58. Europe Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 59. Europe Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 60. Europe Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 61. Europe Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 62. Germany Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 63. France Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 64. UK Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 65. Italy Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 66. Russia Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 67. Middle East & Africa Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 68. Middle East & Africa Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 69. Middle East & Africa Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 71. Egypt Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 72. South Africa Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 73. Israel Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 74. Turkey Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 75. GCC Country Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Drug-Eluting Stent in 2023
Figure 77. Manufacturing Process Analysis of Drug-Eluting Stent
Figure 78. Industry Chain Structure of Drug-Eluting Stent
Figure 79. Channels of Distribution
Figure 80. Global Drug-Eluting Stent Sales Market Forecast by Region (2025-2030)
Figure 81. Global Drug-Eluting Stent Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Drug-Eluting Stent Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Drug-Eluting Stent Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Drug-Eluting Stent Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Drug-Eluting Stent Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Drug-Eluting Stent
Figure 2. Drug-Eluting Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Eluting Stent Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Drug-Eluting Stent Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Drug-Eluting Stent Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Rapamycin Eluting Stent
Figure 10. Product Picture of Paclitaxel Eluting Stent
Figure 11. Product Picture of Everolimus Eluting Stent
Figure 12. Product Picture of Others
Figure 13. Global Drug-Eluting Stent Sales Market Share by Type in 2023
Figure 14. Global Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Figure 15. Drug-Eluting Stent Consumed in Hospitals
Figure 16. Global Drug-Eluting Stent Market: Hospitals (2019-2024) & (K Units)
Figure 17. Drug-Eluting Stent Consumed in Clinics
Figure 18. Global Drug-Eluting Stent Market: Clinics (2019-2024) & (K Units)
Figure 19. Drug-Eluting Stent Consumed in Ambulatory Surgical Centers
Figure 20. Global Drug-Eluting Stent Market: Ambulatory Surgical Centers (2019-2024) & (K Units)
Figure 21. Drug-Eluting Stent Consumed in Others
Figure 22. Global Drug-Eluting Stent Market: Others (2019-2024) & (K Units)
Figure 23. Global Drug-Eluting Stent Sales Market Share by Application (2023)
Figure 24. Global Drug-Eluting Stent Revenue Market Share by Application in 2023
Figure 25. Drug-Eluting Stent Sales Market by Company in 2023 (K Units)
Figure 26. Global Drug-Eluting Stent Sales Market Share by Company in 2023
Figure 27. Drug-Eluting Stent Revenue Market by Company in 2023 ($ Million)
Figure 28. Global Drug-Eluting Stent Revenue Market Share by Company in 2023
Figure 29. Global Drug-Eluting Stent Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Drug-Eluting Stent Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 32. Americas Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 33. APAC Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 34. APAC Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 35. Europe Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 36. Europe Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 37. Middle East & Africa Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 39. Americas Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 40. Americas Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 41. Americas Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 42. Americas Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 43. United States Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 44. Canada Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 45. Mexico Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 46. Brazil Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 47. APAC Drug-Eluting Stent Sales Market Share by Region in 2023
Figure 48. APAC Drug-Eluting Stent Revenue Market Share by Regions in 2023
Figure 49. APAC Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 50. APAC Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 51. China Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 52. Japan Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 53. South Korea Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 54. Southeast Asia Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 55. India Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 56. Australia Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 57. China Taiwan Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 58. Europe Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 59. Europe Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 60. Europe Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 61. Europe Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 62. Germany Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 63. France Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 64. UK Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 65. Italy Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 66. Russia Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 67. Middle East & Africa Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 68. Middle East & Africa Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 69. Middle East & Africa Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 71. Egypt Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 72. South Africa Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 73. Israel Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 74. Turkey Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 75. GCC Country Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Drug-Eluting Stent in 2023
Figure 77. Manufacturing Process Analysis of Drug-Eluting Stent
Figure 78. Industry Chain Structure of Drug-Eluting Stent
Figure 79. Channels of Distribution
Figure 80. Global Drug-Eluting Stent Sales Market Forecast by Region (2025-2030)
Figure 81. Global Drug-Eluting Stent Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Drug-Eluting Stent Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Drug-Eluting Stent Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Drug-Eluting Stent Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Drug-Eluting Stent Revenue Market Share Forecast by Application (2025-2030)
